İçeriğe geç
akaturk Akademik ölçüm
Giriş Kayıt

Akademisyen

SEMA KAYMAZ TAHRA

DOKTOR ÖĞRETİM ÜYESİ (Unvan:Doçent)

BAHÇEŞEHİR ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ

  • Ana Dal Sağlık Bilimleri Temel Alanı
  • Yan Dal Romatoloji

Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.

  • Makale 26
  • Proje 0
  • Kitap 0
  • Bildiri 56
  • Patent 0
  • Sanatsal 0
Scopus (SJR) Q1 11 Q2 7 Q3 4 Q4 4
WoS (JCR) Q1 9 Q2 7 Q3 4 Q4 3
TR Index 7 makale

Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.

Üst %1 makale 0
Üst %10 makale 6
Ort. yüzdelik 67.0%
Üst %1 payı 0.0%
Üst %10 payı 23.1%

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Dizin filtreleri

Toplam 26 yayın

Scopus (SJR)
Q1 11 Q2 7 Q3 4 Q4 4
WoS (JCR)
Q1 9 Q2 7 Q3 4 Q4 3
TR Index
7 makale

Makale listesi

  1. 2025 Genetic susceptibility and validation of angiographic patterns in Takayasu arteritis Journal of Autoimmunity DOI 10.1016/j.jaut.2025.103496 YÖKSİS SJR Q1 JCR Q1 OpenAlex 83.0%
  2. 2025 Involvement of Iliofemoral Arteries in PET/CT Is Associated with Atherosclerotic Risk Factors in Takayasu’s Arteritis Journal of Clinical Medicine DOI 10.3390/jcm14238607 YÖKSİS SJR Q2 JCR Q1 OpenAlex 76.0%
  3. 2025 Genetic susceptibility and validation of angiographic patterns in Takayasu arteritis Journal of Autoimmunity DOI 10.1016/j.jaut.2025.103496 YÖKSİS SJR Q1 JCR Q1 OpenAlex 83.0%
  4. 2025 Turkish Rheumatology Society (Turkish Takayasu Arteritis Study Group) recommendations for the diagnosis, follow-up and the treatment of Takayasus arteritis Clinical and Experimental Rheumatology DOI 10.55563/clinexprheumatol/lptjx1 YÖKSİS SJR Q2 JCR Q2 OpenAlex 69.6%
  5. 2024 Frequency and the effects of spondyloarthritis-spectrum disorders on the clinical course and management of Takayasu arteritis: an observational retrospective study Clinical Rheumatology DOI 10.1007/s10067-024-06939-y YÖKSİS SJR Q2 JCR Q2 OpenAlex 83.6%
  6. 2024 Development of the Takayasu Arteritis Integrated Disease Activity Index Arthritis Care & Research DOI 10.1002/acr.25275 YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 91.8%
  7. 2024 Comparison of methotrexate and azathioprine as the first-line steroid-sparing immunosuppressive agents in patients with Takayasu's arteritis Seminars in Arthritis and Rheumatism DOI 10.1016/j.semarthrit.2024.152446 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 93.6%
  8. 2024 Glucocorticoid toxicity index Acta Medica DOI 10.32552/2024.ActaMedica.1098 YÖKSİS TR Index OpenAlex 29.0%
  9. 2023 Hypogammaglobulinemia and severe infection risk in patients with autoimmune diseases during rituximab treatment Ulusal Romatoloji Dergisi DOI 10.4274/raed.galenos.2023.59144 YÖKSİS TR Index SJR Q4 OpenAlex 15.7%
  10. 2022 Metabolic syndrome is associated with increased cardiovascular risk and disease damage in patients with Takayasu arteritis INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES DOI 10.1111/1756-185X.14335 YÖKSİS SJR Q3 JCR Q3 OpenAlex 74.8%
  11. 2022 The prevalence of non-vascular pulmonary manifestations in Takayasu’s Arteritis patients: A Retrospective multi-centred Turkish cohort study Scandinavian Journal of Rheumatology DOI 10.1080/03009742.2021.1972535 YÖKSİS SJR Q2 JCR Q4 OpenAlex 56.7%
  12. 2022 Pregnancy in Takayasu’s arteritis has a high risk of hypertension‐related fetomaternal complications: A retrospective study of a Turkish cohort International Journal of Rheumatic Diseases DOI 10.1111/1756-185X.14247 YÖKSİS SJR Q3 JCR Q3 OpenAlex 70.2%
  13. 2022 Takayasu arteritinde aktivite değerlendirmesi ve prognoz Ulusal Romatoloji Dergisi DOI 10.4274/raed.galenos.2022.97752 YÖKSİS TR Index SJR Q4 OpenAlex 26.4%
  14. 2021 Identification of susceptibility loci for Takayasu arteritis through a large multi-ancestral genome-wide association study The American Journal of Human Genetics DOI 10.1016/j.ajhg.2020.11.014 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 94.6%
  15. 2021 Biologic treatments in Takayasus Arteritis: A comparative study of tumor necrosis factor inhibitors and tocilizumab Seminars in Arthritis and Rheumatism DOI 10.1016/j.semarthrit.2021.09.010 YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 93.5%
  16. 2021 HADS-depression score is a mediator for illness perception and daily life impairment in Takayasu’s arteritis Clinical Rheumatology DOI 10.1007/s10067-021-05719-2 YÖKSİS SJR Q1 JCR Q3 OpenAlex 74.4%
  17. 2021 Childhood-onset versus adult-onset Takayasu arteritis: A study of 141 patients from Turkey Seminars in Arthritis and Rheumatism DOI 10.1016/j.semarthrit.2020.10.013 YÖKSİS SJR Q1 JCR Q2 OpenAlex 85.5%
  18. 2021 Identification of susceptibility loci for Takayasu arteritis through a large multi-ancestral genome-wide association study The American Journal of Human Genetics DOI 10.1016/j.ajhg.2020.11.014 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 94.6%
  19. 2020 Assessment of damage in Takayasu‘s arteritis Seminars in Arthritis and Rheumatism DOI 10.1016/j.semarthrit.2020.04.003 YÖKSİS SJR Q1 JCR Q1 OpenAlex 85.9%
  20. 2018 Certolizumab pegol in the treatment of Takayasu arteritis Rheumatology DOI 10.1093/rheumatology/key197 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 91.8%

Akademisyenlere dön